Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy

This billing and coding article (A56881) provides guidelines that complement the Local Coverage Determination MolDX: HLA-DQB1*06:02 Testing for Narcolepsy (LCD L36485). The document does not itself state clinical coverage criteria; coverage and coding determinations should follow LCD L36485 and associated MolDX rules.

"Billing, coding, and other claim guidelines for HLA-DQB1*06:02 testing for narcolepsy must follow and complement the Local Coverage Determination MolDX: HLA-DQB1*06:02 Testing for Narcolepsy (LCD L..."

Sign up to see full coverage criteria, indications, and limitations.